{"id":"https://openalex.org/W2013282919","doi":"https://doi.org/10.1186/1471-2407-7-36","title":"HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination","display_name":"HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination","publication_year":2007,"publication_date":"2007-02-26","ids":{"openalex":"https://openalex.org/W2013282919","doi":"https://doi.org/10.1186/1471-2407-7-36","mag":"2013282919","pmid":"https://pubmed.ncbi.nlm.nih.gov/17324279","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1820790"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2407-7-36","doi":"https://doi.org/10.1186/1471-2407-7-36","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-7-36","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-7-36","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2013282919"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-7-36","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008447927","display_name":"Daniel Guimar\u00e3es Tiezzi","orcid":"https://orcid.org/0000-0002-2660-0093","observed_orcids":["https://orcid.org/0000-0002-2660-0093"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Daniel G Tiezzi","raw_affiliation_strings":["Department of Gynecology and Obstetrics, Breast Disease Division, Ribeirao Preto School of Medicine, HCFMRP-USP, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil. daniel.tiezzi@yahoo.com","Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeir\u00e3o Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecology and Obstetrics, Breast Disease Division, Ribeirao Preto School of Medicine, HCFMRP-USP, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil. daniel.tiezzi@yahoo.com","institution_ids":["https://openalex.org/I17974374"]},{"raw_affiliation_string":"Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeir\u00e3o Preto, Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090278499","display_name":"Jurandyr Moreira de Andrade","orcid":"https://orcid.org/0000-0003-3619-0582","observed_orcids":["https://orcid.org/0000-0003-3619-0582"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Jurandyr M Andrade","raw_affiliation_strings":["Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Av Bandeirantes, 3900, 14048-900, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil","Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeir\u00e3o Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Av Bandeirantes, 3900, 14048-900, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I17974374"]},{"raw_affiliation_string":"Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeir\u00e3o Preto, Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051554413","display_name":"Alfredo Ribeiro\u2010Silva","orcid":"https://orcid.org/0000-0002-3579-5048","observed_orcids":["https://orcid.org/0000-0002-3579-5048"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Alfredo Ribeiro-Silva","raw_affiliation_strings":["Department of Pathology \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeirao Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeirao Preto, Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049802686","display_name":"F\u00e1bio Eduardo Zola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"F\u00e1bio E Zola","raw_affiliation_strings":["Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Av Bandeirantes, 3900, 14048-900, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil","Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeir\u00e3o Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Av Bandeirantes, 3900, 14048-900, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I17974374"]},{"raw_affiliation_string":"Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeir\u00e3o Preto, Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108443256","display_name":"Heitor Ricardo Cosiski Marana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Heitor RC Marana","raw_affiliation_strings":["Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Av Bandeirantes, 3900, 14048-900, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil","Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeir\u00e3o Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Av Bandeirantes, 3900, 14048-900, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I17974374"]},{"raw_affiliation_string":"Department of Gynecology and Obstetrics \u2013 Breast Disease Division \u2013 Ribeirao Preto School of Medicine \u2013 HCFMRP- USP, Ribeir\u00e3o Preto, Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038400415","display_name":"Marcelo Guimar\u00e3es Tiezzi","orcid":"https://orcid.org/0000-0002-1355-9212","observed_orcids":["https://orcid.org/0000-0002-1355-9212"]},"institutions":[{"id":"https://openalex.org/I4210124356","display_name":"Hospital Regional de Presidente Prudente","ror":"https://ror.org/03xzqpb53","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210124356"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Marcelo G Tiezzi","raw_affiliation_strings":["Colaborating Pathologist from Presidente Prudente Laboratory of Pathology and Cytopathology, S/A, Presidente Prudente, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Colaborating Pathologist from Presidente Prudente Laboratory of Pathology and Cytopathology, S/A, Presidente Prudente, Brazil","institution_ids":["https://openalex.org/I4210124356"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5008447927"],"corresponding_institution_ids":["https://openalex.org/I17974374"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":2.6588,"has_fulltext":true,"cited_by_count":71,"citation_normalized_percentile":{"value":0.91384943,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"7","issue":"1","first_page":"36","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.8220000267028809},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9789999723434448},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.9929999709129333},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.7239999771118164},{"id":"https://openalex.org/keywords/progesterone-receptor","display_name":"progesterone receptor","score":1.0},{"id":"https://openalex.org/keywords/hormone-receptors","display_name":"hormone receptors","score":0.6639999747276306},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.8700000047683716},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9940000176429749},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9160000085830688},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7689999938011169},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.7749999761581421},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pathological-response","display_name":"pathological response","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9114505052566528},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.7795512080192566},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7500730752944946},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7474215626716614},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7052419185638428},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.6581512689590454},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.6574572324752808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6443933844566345},{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.596585750579834},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5552734136581421},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5302728414535522},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.4904288947582245},{"id":"https://openalex.org/C2780521871","wikidata":"https://www.wikidata.org/wiki/Q7239671","display_name":"Predictive marker","level":3,"score":0.46539247035980225},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4359918236732483},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3815971314907074}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1186/1471-2407-7-36","doi":"https://doi.org/10.1186/1471-2407-7-36","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-7-36","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-7-36","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:1817528","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1820790","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:17324279","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17324279","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:1820790","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1820790/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmh:oai:www.producao.usp.br:BDPI/32867","doi":null,"is_oa":true,"landing_page_url":"http://www.producao.usp.br/handle/BDPI/32867","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"reponame:Reposit\u00f3rio Institucional da USP","raw_type":"publishedVersion"},{"id":"pmh:oai:doaj.org/article:eeab8163fc6a432aab89f2f05fab5c5d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/eeab8163fc6a432aab89f2f05fab5c5d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, Vol 7, Iss 1, p 36 (2007)","raw_type":"article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.279.4129","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.279.4129","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/69/93/BMC_Cancer_2007_Feb_26_7_36.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1186/1471-2407-7-36","doi":"https://doi.org/10.1186/1471-2407-7-36","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-7-36","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-7-36","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"},{"id":"https://openalex.org/F4320335309","display_name":"Funda\u00e7\u00e3o de Apoio ao Ensino, Pesquisa e Assist\u00eancia do Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo","ror":"https://ror.org/011rw2y56"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2013282919.pdf","grobid_xml":"https://content.openalex.org/works/W2013282919.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1930298597","https://openalex.org/W1955397179","https://openalex.org/W1974135529","https://openalex.org/W1992944232","https://openalex.org/W2036294483","https://openalex.org/W2046189140","https://openalex.org/W2048045188","https://openalex.org/W2050466428","https://openalex.org/W2052151176","https://openalex.org/W2059102920","https://openalex.org/W2064367468","https://openalex.org/W2066747782","https://openalex.org/W2069548442","https://openalex.org/W2080252511","https://openalex.org/W2082814305","https://openalex.org/W2086766680","https://openalex.org/W2090099441","https://openalex.org/W2098262535","https://openalex.org/W2104528117","https://openalex.org/W2113242459","https://openalex.org/W2114840421","https://openalex.org/W2131686669","https://openalex.org/W2133585870","https://openalex.org/W2135424430","https://openalex.org/W2139510434","https://openalex.org/W2142495011","https://openalex.org/W2156394189","https://openalex.org/W2156544288","https://openalex.org/W2204696794","https://openalex.org/W2405055043","https://openalex.org/W4301697311"],"related_works":["https://openalex.org/W213957447","https://openalex.org/W1974135529","https://openalex.org/W2248553349","https://openalex.org/W1563147852","https://openalex.org/W2371925745","https://openalex.org/W2052687613","https://openalex.org/W2038377929","https://openalex.org/W2386491285","https://openalex.org/W2365134123"],"abstract_inverted_index":{"BACKGROUND:":[0],"Neoadjuvant":[1],"chemotherapy":[2,97,126,249],"has":[3],"been":[4],"considered":[5],"the":[6,18,42,121,128,160,254],"standard":[7],"care":[8],"in":[9,52,77,83,86,170,178,204,244,258],"locally":[10],"advanced":[11],"breast":[12,57,107,263],"cancer.":[13],"However,":[14],"about":[15],"20%":[16],"of":[17,30,44,131,162,172,242],"patients":[19,59,71,173,245,265],"do":[20],"not":[21,33,187,226],"benefit":[22],"from":[23],"this":[24],"clinical":[25,168],"treatment":[26,166],"and,":[27,194],"predictive":[28],"factors":[29],"response":[31,49,112,122,169,177,191,230,235],"were":[32,114,186,225],"defined":[34],"yet.":[35],"This":[36],"study":[37],"was":[38,148,199],"designed":[39],"to":[40,47,124,189,192,228,231,247],"evaluate":[41],"importance":[43],"biological":[45],"markers":[46],"predict":[48,190,229],"and":[50,55,63,110,127,133,140,174,183,207,213,250,261,271],"prognosis":[51],"stage":[53,259],"II":[54,260],"III":[56,262],"cancer":[58,264],"treated":[60,266],"with":[61,79,98,151,201,239,267],"taxane":[62],"anthracycline":[64],"combination":[65,78],"as":[66,217],"neoadjuvant":[67,125,232,248,269],"setting.":[68],"METHODS:":[69],"Sixty":[70],"received":[72,95],"preoperative":[73,117],"docetaxel":[74,270],"(75":[75],"mg/m2)":[76,82],"epirubicin":[80,272],"(50":[81],"i.v.":[84],"infusion":[85],"D1":[87],"every":[88],"3":[89],"weeks":[90],"after":[91,116,159],"incisional":[92],"biopsy.":[93],"They":[94],"adjuvant":[96],"CMF":[99],"or":[100],"FEC,":[101],"attaining":[102],"axillary":[103],"status":[104],"following":[105],"definitive":[106],"surgery.":[108],"Clinical":[109,234],"pathologic":[111,176],"rates":[113],"measured":[115],"therapy.":[118],"We":[119],"evaluated":[120],"rate":[123],"prognostic":[129,256],"significance":[130],"clinicopathological":[132],"immunohistochemical":[134,184],"parameters":[135,185],"(ER,":[136],"PR,":[137],"p51,":[138],"p21":[139],"HER-2":[141],"protein":[142,197],"expression).":[143],"The":[144,180],"median":[145,153],"patient":[146],"age":[147],"50.5":[149],"years":[150],"a":[152,202,240,268],"follow":[154],"up":[155],"time":[156,161],"48":[157],"months":[158],"diagnosis.":[163],"RESULTS:":[164],"Preoperative":[165],"achieved":[167],"76.6%":[171],"complete":[175],"5%.":[179],"clinical,":[181],"pathological":[182],"able":[188,227],"therapy":[193],"only":[195],"HER2":[196,251],"overexpression":[198,252],"associated":[200],"decrease":[203],"disease":[205],"free":[206],"overall":[208],"survival":[209],"(P":[210],"=":[211,215],"0.0007":[212],"P":[214],"0.003)":[216],"shown":[218],"by":[219],"multivariate":[220],"analysis.":[221],"CONCLUSION:":[222],"Immunohistochemical":[223],"phenotypes":[224],"chemotherapy.":[233],"is":[236,253],"inversely":[237],"correlated":[238],"risk":[241],"death":[243],"submitted":[246],"major":[255],"factor":[257],"combination.":[273]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
